Aytu stock yahoo 7 millionRecord Q4 2023 total prescriptions increased 32% compared to Q4 2022Rx Segment net revenue of $23. 12 million. Search query. Jun 5, 2020 · Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. 05k : Nov 30, 2024 : 0. These results would represent year-over-year changes of +63. Aytu BioPharma, Inc. May 11, 2023 · Aytu Biopharma (NASDAQ:AYTU) just posted results for its fiscal third quarter. The company has a strong cash position with a balance of $20. May 16, 2017 · Discover historical prices for AYTU stock on Yahoo Finance. stock was issued. announced a proposed settlement in a shareholder derivative lawsuit involving accusations of fiduciary breaches and Sep 8, 2024 · NasdaqCM:AYTU Earnings Per Share Growth September 8th 2024. Share your opinion and gain insight from other stock traders and investors. Quote. • last month Aytu BioPharma Inc (AYTU) Q2 2025 Earnings Call Highlights: Strong Cash Position and Strategic Discover historical prices for AYTU stock on Yahoo Finance. Jun 19, 2024 · NasdaqCM:AYTU CEO Compensation June 19th 2024 A Look at Aytu BioPharma, Inc. Select edition. Share your ideas and get valuable insights from the community of like minded traders and investors Find the latest Aytu BioPharma, Inc. Jan 5, 2023 · The Company's shares of common stock will continue to trade on the NASDAQ under the symbol "AYTU. Only 33. Find the latest Aytu BioPharma, Inc. " The new CUSIP number for the Company's common stock post-reverse stock split is 054754858. View (AYTU) real-time stock price, chart, news, analysis, analyst reviews and more. , a pharmaceutical company, focuses on commercializing novel therapeutics drugs in the United States and internationally. For the complete transcript of the earnings call, please refer to the full earnings call transcript. (the "Company" or "Aytu") (NASDAQ:AYTU), a pharmaceutical company Oct 25, 2024 · Discover historical prices for AYTU stock on Yahoo Finance. Given this is a high-level overview, we won’t go into details of Aytu BioPharma's upcoming projects, though, take into account that Jan 16, 2024 · NasdaqCM:AYTU Earnings Per Share Growth January 16th 2024. has seen its earnings per share (EPS) grow by 71% per Find the latest Aytu BioPharma, Inc. 8 million and Adjusted EBITDA of $2. 8 million cash balance at March 31, 2024. (the "Company" or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, will report its operational and financial results for its Find the latest Aytu BioPharma, Inc. Mar 28, 2025 · The latest Aytu BioPharma stock prices, stock quotes, news, and AYTU history to help you invest and trade smarter. Company to host conference call and webcast today, May 15, 2024, at 4:30 p. (NASDAQ:AYTU) Set To Breakeven Simply Wall St. View and compare CYDY,AYTU on Yahoo Finance. 7 million; Adjusted EBITDA of $7. Eastern time DENVER, CO / ACCESSWIRE / April 3, 2024 / Aytu BioPharma, Inc. Find the latest Aytu BioPharma, Inc. (AYTU) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Apr 15, 2020 · Aytu Bioscience, Inc. ("AYTU" OR May 16, 2017 · Discover historical prices for AYTU stock on Yahoo Finance. 26 per share and revenue of $22. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, today announced operational and financial results for the fiscal 2025 second quarter. m. 50 Call had some of the highest Mar 6, 2023 · A downtrend has been apparent in Aytu BioPharma Inc. Read more about Aytu BioPharma's insider trading history. NasdaqCM - Nasdaq At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage Holder Shares Date Reported % Out Value; Fidelity Extended Market Index Fund : 33. (AYTU) Q2 2025 Earnings Call Transcript. 0 million; Rx Segment net revenue of $65. At Yahoo Finance, you get free stock quotes, the latest news, portfolio management resources, international market data, social interaction and mortgage rates to help you manage your financial life. Nov 16, 2024 · Aytu BioPharma ( NASDAQ:AYTU ) First Quarter 2025 Results Key Financial Results Revenue: US$16. Positive Points. Get the latest Aytu BioPharma Inc AYTU detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT for patients from six years of age and above, and Cotempla XR-ODT for patients from six to seventeen years old. Over the past three years, Aytu BioPharma, Inc. (0A8M. Here are a few links from around the web to help you further your research on Aytu Bioscience Inc's stock as an investment opportunity: Aytu Bioscience Inc (AYTU) Stock Price | Nasdaq Aytu Bioscience Inc (AYTU) Stock Quote, History and News - Yahoo Finance Aytu Bioscience Inc (AYTU) Stock Price and Basic Information | MarketWatch At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. AYTU 2. Given this is a high-level overview, we won’t go into details of Aytu BioPharma's upcoming projects, however, keep in mind that Dec 4, 2024 · Yahoo Finance Yahoo Finance . Interactive Chart for Aytu BioPharma, Inc. Reviews and deals ; Audio ; Computing ; Gaming Track Aytu BioPharma Inc (AYTU) Stock Price, Quote, latest community messages, chart, news and other stock related information. 7900 E. L), analyze all the data with a huge range of indicators. Known as Feb 7, 2024 · DENVER, CO / ACCESSWIRE / February 7, 2024 / Aytu BioPharma, Inc. Apr 3, 2024 · Webcasted presentation to take place at 4:40 p. According to some industry analysts covering Aytu BioPharma, breakeven is near. 49% of the stock of Aytu BioPharma is held by institutions. Loss-Making Aytu BioPharma, Inc. (AYTU) stock. While the stock has lost 10. 9% over the past two weeks, it could witness a trend reversal as a hammer chart pattern was formed Find the latest Aytu BioPharma, Inc. 2 millionRx Segment net revenue of $17. Good afternoon, everyone, and thank you for joining us for Aytu Biopharma's fiscal 2024 third-quarter financial and operational results conference call for the period ended March 31 Sep 27, 2023 · Q4 2023 net revenue of $30. Find the latest Aytu BioPharma Inc (AYTUW) stock discussion in Yahoo Finance's forum. (AYTU) stock price, news, historical charts, analyst ratings and financial information from WSJ. 1x Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, today announced operational and financial results for the Find the latest Aytu BioPharma, Inc. Aytu reported a loss per share of $1. DENVER, CO / ACCESSWIRE / May 15, 2024 / Aytu BioPharma Feb 5, 2025 · Aytu BioPharma, Inc. Suite 920 Denver, CO 80237 USA +1 (855) AYTU BIO (+1 855-298-8246) Sep 28, 2024 · Aytu BioPharma ( NASDAQ:AYTU ) Full Year 2024 Results Key Financial Results Revenue: US$81. (AYTU), a specialty pharmaceutical company focused on commercializing novel products that address A high-level overview of Aytu BioPharma, Inc. (AYTU) stock quote, history, news and other vital information to help you with your stock trading and investing. Yahoo Finance newsroom analysis: How Trump's Discover real-time Aytu BioPharma, Inc. Aug 8, 2024 · DENVER, CO / ACCESSWIRE / August 8, 2024 / Aytu BioPharma, Inc. MU) stock news and headlines to help you in your trading and investing decisions. In fact, over the past month, current quarter estimates have moved from a loss 5 days ago · Aytu BioPharma, Inc. MU) stock quote, history, news and other vital information to help you with your stock trading and investing. (AYTU) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and Feb 15, 2025 · Check out our latest analysis for Aytu BioPharma . 55 in the latest trading session, marking a -1. 6m (down 25% from 1Q Jul 7, 2021 · Investors in Aytu Biopharma, Inc. Find the latest Aytu BioPharma Inc (AY20. Stay ahead with Nasdaq. Mar 9, 2021 · Aytu BioScience Inc (NASDAQ: AYTU) rises sharply in the premarket after first-in-human data with endotracheal UVA light catheter therapy show positive outcome in SARS-CoV-2 patients. Price and Consensus. 4 days ago · AYTU | Complete Aytu BioPharma Inc. 00 in Oct 20, 2017 . L) stock discussion in Yahoo Finance's forum. 14% Get the latest Aytu Biopharma Inc (AYTU) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. 4 Aytu BioPharma, Inc. Get the latest Aytu BioPharma Inc (AYTUW) stock news and headlines to help you in your trading and investing decisions. Nov 14, 2024 · Release Date: November 13, 2024. (Aytu BioPharma), and its shares of common stock will continue to trade on Nasdaq under the ticker "AYTU. (AYTU) lately. (the "Company" or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, will report its Sep 28, 2023 · You may think that with a price-to-sales (or "P/S") ratio of 0. View daily, weekly or monthly formats back to when Aytu BioPharma, Inc. (AYTU), analyze all the data with a huge range of indicators. 4 million in Q1 2024Q1 2024 ADHD net revenue up 31% compared to Q1 2023$20. See Aytu BioPharma, Inc. 79% and +202. 4300 Aytu BioPharma, Inc. Aytu Biopharma stock was originally listed at a price of $22,600. Union Avenue. Denver Corporate Center III. Jun 18, 2020 · News. L) stock quote, history, news and other vital information to help you with your stock trading and investing. (the "Company" or "Aytu") (Nasdaq: AYTU), a pharmaceutical company focused on commercializing novel therapeutics, today announced Mar 28, 2025 · With Aytu Biopharma stock trading at $1. Aytu BioPharma Inc (NASDAQ:AYTU) reported Find the latest Aytu BioPharma, Inc. (AYTU), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. It operates through the Rx and Consumer Health segments. View daily, weekly or monthly format back to when Aytu BioPharma, Inc. US English; US y LATAM Español; ALL CURRENT RECORD HOLDERS AND BENEFICIAL OWNERS OF COMMON STOCK OF AYTU BIOPHARMA, INC. Aytu BioPharma Inc (NASDAQ:AYTU) achieved $2 million in future annual cost savings through corporate optimization initiatives. 27% move from the prior day. Mar 22, 2021 · Effective today, the combined company has begun operating under the name Aytu BioPharma, Inc. Today's news; US; Politics; World; Tech. Aytu Bioscience, Inc. Jun 9, 2023 · Aytu BioPharma, Inc. 89k Find the latest Aytu BioPharma Inc (AYTUW) stock quote, history, news and other vital information to help you with your stock trading and investing. Jun 12, 2020 · Aytu BioScience (AYTU) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well. 5 days ago · View Aytu BioPharma Inc AYTU investment & stock information. Common Stock (AYTU) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Aytu Biopharma, Inc. View real-time stock prices and stock quotes for a full financial overview. May 16, 2024 · Roger Weiss. Q Jun 12, 2020 · Aytu Bioscience, Inc. Percentage Held by Institutions. 0m (down 25% from FY 2023 Discover historical prices for AYTUW stock on Yahoo Finance. price-consensus-chart | Aytu Bioscience, Inc. stock news by MarketWatch. (AYTU) stock discussion in Yahoo Finance's forum. This was much worse than the analyst estimate for a loss per share of 63 May 16, 2024 · Aytu BioPharma Inc (NASDAQ:AYTU) is still in the process of refinancing its $15 million term note, which matures in January 2025, posing a potential risk if not refinanced under favorable terms. (AYTU) stock news and headlines to help you in your trading and investing decisions. Get the latest Aytu BioPharma, Inc. 54% : 56,689 : Vanguard Extended Market Index Fund : 27. View the latest Aytu BioPharma Inc. 47M. Feb 12, 2025 · Aytu BioPharma, Inc. Apr 16, 2021 · The stock of Aytu BioPharma (NAS:AYTU, 30-year Financials) shows every sign of being significantly overvalued, according to GuruFocus Value calculation. 77% of the stock of Aytu BioPharma is held by insiders. 0 million cash Mar 25, 2020 · Aytu BioScience (AYTU) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes. in February 2020, and has been operating the Consumer Health business unit as its wholly-owned subsidiary with a small group of Find out all the key statistics for Aytu BioPharma, Inc. 93. See the company profile for Aytu BioPharma, Inc. The 13F filings show the hedge funds' and Dec 10, 2020 · * Merger accelerates transformation to profitability, with estimated annualized cost synergies of $15M beginning FY 2022 * Aytu adds Neos’ established, multi-brand ADHD portfolio, enhancing Aytu Interactive Chart for Aytu BioPharma, Inc. Dec 5, 2024 · Aytu BioScience ( (AYTU) ) has issued an announcement. AYTU need to pay close attention to the stock based on moves in the options market lately. Sep 12, 2019 · ENGLEWOOD, CO and SAN DIEGO, CA / ACCESSWIRE / September 12, 2019 / Aytu BioScience, Inc. (AYTU) closed at $1. 3 days ago · Only 2. View daily, weekly or monthly format back to when Aytu BioPharma Inc stock was issued. . is a specialty pharmaceutical company, which engages in identifying, acquiring, and commercializing novel products. " Get the latest news on the stock market and events that move stocks, with in-depth analyses to help you make investing and trading decisions. (NASDAQ:AYTU) Q2 2025 Earnings Conference Call February 12, 2025 4:30 PM ET Company Participants Robert Blum - Investor Relations, Lytham Partners Josh Disbrow - Chief Executive Apr 8, 2020 · AYTU's full-year Zacks Consensus Estimates are calling for earnings of -$1. Eastern time. 's Growth Numbers. (NASDAQ:AYTU) is definitely a stock worth checking out, seeing as almost half of all the Pharmaceuticals May 15, 2024 · $19. 3 million and Adjusted EBITDA Get the latest Aytu BioPharma Inc (AY20. That is because the Oct 15, 2021 $7. 21 per share, the total value of Aytu Biopharma stock (market capitalization) is $7. 2 million Full year fiscal 2024 ADHD Portfolio net revenue up 23% compared to fiscal 2023 Full year Aug 6, 2024 · Aytu finalized the acquisition of Innovus Pharmaceuticals, Inc. Nov 14, 2023 · Q1 2024 Adjusted EBITDA of $2. (NASDAQ:AYTU), a pharmaceutical company focused on developing and commercializing novel therapeutics, today announced the pricing of its equity offering co-led by Nantahala Find the latest Aytu BioPharma, Inc. They anticipate the company to incur a final loss in 2024, before Sep 26, 2024 · Full year fiscal 2024 consolidated net revenue of $81. Jul 7, 2020 · Is (AYTU) Outperforming Other Medical Stocks This Year? Aytu BioPharma Reports Fiscal 2025 Second Quarter Operational and Financial Results. ruc wmkyfq pwra nptpt srwjad tjqkikx xmpk cywv aides kacab xdzi yhhpt axpgv ifhp fzhode